CURIS, INC. Payments to Acquire Marketable Securities
CURIS, INC. (CRIS) reported Payments to Acquire Marketable Securities of $93.13 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2022-02-24
- CURIS, INC. payments to acquire marketable securities for the quarter ending 2019-12-31 was $551.00K, a 7.55% decline year-over-year.
- CURIS, INC. payments to acquire marketable securities for the quarter ending 2019-09-30 was $2.90M, a 44.43% decline year-over-year.
- CURIS, INC. payments to acquire marketable securities for the quarter ending 2019-06-30 was $8.02M, a 91.52% increase year-over-year.
- CURIS, INC. payments to acquire marketable securities for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. payments to acquire marketable securities for fiscal 2021 was $93.13M, a 74.23% increase from fiscal 2020.
- CURIS, INC. payments to acquire marketable securities for fiscal 2020 was $53.45M, a 366.19% increase from fiscal 2019.
- CURIS, INC. payments to acquire marketable securities for fiscal 2019 was $11.46M, a 57.13% decline from fiscal 2018.
- CURIS, INC. payments to acquire marketable securities for fiscal 2018 was $26.74M, a 47.69% decline from fiscal 2017.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 3 month as first filed | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 6 month as first filed | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 9 month as first filed | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $93.13M 10-K · filed 2022-02-24 | |||||||
| 2020-12-31 | $53.45M 10-K · filed 2022-02-24 | |||||||
| 2019-12-31 | $551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.45M derived: sum of 2 quarters · filed 2022-02-24 | $11.46M derived: sum of 3 quarters · filed 2022-02-24 | $11.46M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $10.91M derived: sum of 2 quarters · filed 2019-11-05 | $10.91M 10-Q · filed 2019-11-05 | $11.51M derived: sum of 4 quarters · filed 2020-03-19 | ||||
| 2019-06-30 | $8.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $8.02M 10-Q · filed 2019-08-09 | $8.61M derived: sum of 3 quarters · filed 2020-03-19 | $13.83M derived: sum of 4 quarters · filed 2020-03-19 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 | $596.00K derived: sum of 2 quarters · filed 2020-03-19 | $5.81M derived: sum of 3 quarters · filed 2020-03-19 | $9.99M derived: sum of 4 quarters · filed 2020-03-19 | ||||
| 2018-12-31 | $596.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $5.81M derived: sum of 2 quarters · filed 2020-03-19 | $9.99M derived: sum of 3 quarters · filed 2020-03-19 | $26.74M 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | $5.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $9.40M derived: sum of 2 quarters · filed 2019-11-05 | $26.14M 10-Q · filed 2019-11-05 | $32.98M derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | $4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $20.93M 10-Q · filed 2019-08-09 | $27.76M derived: sum of 3 quarters · filed 2019-08-09 | $44.58M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $16.75M 10-Q · filed 2019-05-14 | $23.58M derived: sum of 2 quarters · filed 2019-05-14 | $40.39M derived: sum of 3 quarters · filed 2019-05-14 | $55.31M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $6.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $23.64M derived: sum of 2 quarters · filed 2019-03-26 | $38.56M derived: sum of 3 quarters · filed 2019-03-26 | $51.12M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $16.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $31.73M derived: sum of 2 quarters · filed 2018-11-01 | $44.29M 10-Q · filed 2018-11-01 | $51.45M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $14.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $27.48M 10-Q · filed 2018-08-02 | $34.63M derived: sum of 3 quarters · filed 2018-08-02 | $36.37M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $12.56M 10-Q · filed 2018-05-03 | $19.71M derived: sum of 2 quarters · filed 2018-05-03 | $21.45M derived: sum of 3 quarters · filed 2018-05-03 | $40.73M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | $7.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $8.89M derived: sum of 2 quarters · filed 2018-03-08 | $28.17M derived: sum of 3 quarters · filed 2018-03-08 | $57.64M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $21.02M derived: sum of 2 quarters · filed 2017-11-07 | $50.48M 10-Q · filed 2017-11-07 | $78.13M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | $19.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $48.74M 10-Q · filed 2017-08-03 | $76.39M derived: sum of 3 quarters · filed 2018-03-08 | $105.69M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | $29.47M 10-Q · filed 2017-05-04 | $29.47M 10-Q · filed 2016-05-09 | $57.11M derived: sum of 2 quarters · filed 2018-03-08 | $86.41M derived: sum of 3 quarters · filed 2018-03-08 | $95.15M derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2015-12-31 | $27.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $56.94M derived: sum of 2 quarters · filed 2018-03-08 | $65.68M derived: sum of 3 quarters · filed 2018-03-08 | $123.24M 10-K · filed 2018-03-08 | $123.24M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $29.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $38.03M derived: sum of 2 quarters · filed 2016-11-03 | $95.59M 10-Q · filed 2016-11-03 | $95.60M 10-Q · filed 2015-11-09 | $98.71M derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2015-06-30 | $8.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $66.30M 10-Q · filed 2016-08-04 | $66.30M 10-Q · filed 2015-08-06 | $69.41M derived: sum of 3 quarters · filed 2017-03-09 | $82.35M derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2015-03-31 | $57.56M 10-Q · filed 2016-05-09 | $60.68M derived: sum of 2 quarters · filed 2017-03-09 | $73.61M derived: sum of 3 quarters · filed 2017-03-09 | $85.57M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2014-12-31 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $16.05M derived: sum of 2 quarters · filed 2017-03-09 | $28.01M derived: sum of 3 quarters · filed 2017-03-09 | $41.40M 10-K · filed 2017-03-09 | $41.40M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $12.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $24.90M derived: sum of 2 quarters · filed 2015-11-09 | $38.28M 10-Q · filed 2015-11-09 | $60.20M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $11.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $25.35M 10-Q · filed 2015-08-06 | $47.27M derived: sum of 3 quarters · filed 2016-02-29 | $63.47M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $13.39M 10-Q · filed 2015-05-07 | $35.31M derived: sum of 2 quarters · filed 2016-02-29 | $51.51M derived: sum of 3 quarters · filed 2016-02-29 | $69.13M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $21.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $38.12M derived: sum of 2 quarters · filed 2016-02-29 | $55.74M derived: sum of 3 quarters · filed 2016-02-29 | $65.83M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $16.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $33.82M derived: sum of 2 quarters · filed 2014-11-10 | $43.91M 10-Q · filed 2014-11-10 | $69.11M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $17.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $27.70M 10-Q · filed 2014-08-07 | $52.90M derived: sum of 3 quarters · filed 2015-02-24 | $66.69M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $10.09M 10-Q · filed 2014-05-09 | $35.29M derived: sum of 2 quarters · filed 2015-02-24 | $49.08M derived: sum of 3 quarters · filed 2015-02-24 | $57.50M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $25.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $38.99M derived: sum of 2 quarters · filed 2015-02-24 | $47.41M derived: sum of 3 quarters · filed 2015-02-24 | $69.15M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $13.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $22.21M derived: sum of 2 quarters · filed 2013-11-12 | $43.96M 10-Q · filed 2013-11-12 | $43.21M 10-Q · filed 2012-11-06 | $53.86M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2012-06-30 | $8.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $30.16M 10-Q · filed 2013-08-08 | $40.06M derived: sum of 3 quarters · filed 2014-03-13 | $46.69M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $21.74M 10-Q · filed 2013-05-09 | $31.64M derived: sum of 2 quarters · filed 2014-03-13 | $38.27M derived: sum of 3 quarters · filed 2014-03-13 | $45.01M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $16.53M derived: sum of 2 quarters · filed 2014-03-13 | $23.27M derived: sum of 3 quarters · filed 2014-03-13 | $42.14M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $6.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $13.37M derived: sum of 2 quarters · filed 2012-11-06 | $32.24M 10-Q · filed 2012-11-06 | $44.24M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-06-30 | $6.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $25.61M 10-Q · filed 2012-08-09 | $37.61M derived: sum of 3 quarters · filed 2013-03-13 | $56.83M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-03-31 | $18.86M 10-Q · filed 2012-05-10 | $30.86M derived: sum of 2 quarters · filed 2013-03-13 | $50.09M derived: sum of 3 quarters · filed 2013-03-13 | |||||
| 2010-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $31.22M derived: sum of 2 quarters · filed 2013-03-13 | $65.90M 10-K · filed 2013-03-13 | |||||
| 2010-09-30 | $19.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $53.90M 10-Q · filed 2011-10-31 | ||||||
| 2010-06-30 | $34.67M 10-Q · filed 2011-08-04 | |||||||
| 2009-12-31 | $35.83M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |